Fluorescence resonance energy transfer analysis reveals the existence of endothelin-A and endothelin-B receptor homodimers

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Gregan, Bernd ^a   Schaefer, Michael ^a   Rosenthal, Walter ^a,b   Oksche, Alexander ^a,b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c Institut fur Pharmakologie   (Germany)

Author keywords

Endothelin (ET); Fluorescence resonance energy transfer (FRET); G protein coupled receptor; Homodimerization

Indexed keywords

CYAN FLUORESCENT PROTEIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIMER; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; HYBRID PROTEIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; YELLOW FLUORESCENT PROTEIN;

CONFERENCE PAPER; CONTROLLED STUDY; DIMERIZATION; EMBRYO; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING;

EID: 11144271570     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166218.35168.79     Document Type: Conference Paper

References (12)

1. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of cDNA encoding an endothelin receptor. Nature. 1990; 348:730-732.
2. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
3. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 1994;89:1203-1208.
4. de Nucci G, Thomas R, D'Orleans Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U.S.A. 1998;85:9797-9800.
5. Bouvier M. Oligomerization of G protein-coupled transmitter receptors. Nat Rev Neurosci. 2001;2:274-286.
6. Devi LA. Heterodimerization of G protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci. 2001; 22:532-537.
7. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M. Qualitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization. J Biol Chem. 2002;277:44925-44931.
8. 2 receptor homodimer. J Biol Chem. 2003; 278:4385-4388.
9. Oksche A, Boese G, Horstmeyer A, et al. Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupled endothelin B receptor. Mol Pharmacol. 2000;57:1104-1113.
10. Brock C, Schaefer M, Reusch HP, et al. Roles of Gβγin membrane recruitment and activation of p110γ/p101 phosphoinositide-3-kinase. J Cell Biol. 2003;160:89-99.
11. Terrillon S, Durrox I, Mouillac B, et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive heterodimers during biosynthesis. Mol Endocrinol. 2003;17:677-691.
12. Latif R, Graves P, Davies TF. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J Biol Chem. 2002; 277:45059-45067.